Inhibitor Therapeutics
(OTC) INTI
Inhibitor Therapeutics Financials at a Glance
Market Cap
$15.19M
Revenue (TTM)
$0.00
Net Income (TTM)
$3.43M
EPS (TTM)
$-0.02
P/E Ratio
-4.42
Dividend
$0.00
Beta (Volatility)
-0.22 (Low)
Dividend
$0.00
Beta (Volatility)
-0.22 (Low)
Price
$0.09
Volume
150
Open
$0.09
Price
$0.09
Volume
150
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.03 - $0.12
Dividend
$0.00
Beta (Volatility)
-0.22 (Low)
Price
$0.09
Volume
150
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.03 - $0.12
INTI News
INTI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inhibitor Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
Frank E. O'Donnell, Jr.
Website
www.inhibitortx.comHeadquarters
Tampa, FL 33602, US
INTI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-201%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-22.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$15.19M
Shares Outstanding
172.57M
Volume
150
Short Interest
0.00%
Avg. Volume
26.02K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.66M
EBITDA
$318.00K
Operating Cash Flow
$3.23M
Capital Expenditure
$0.00
Free Cash Flow
$3.23M
Cash & ST Invst.
$5.61M
Total Debt
$0.00
Inhibitor Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$15.19M
N/A
Market Cap/Employee
$5.06M
N/A
Employees
3
N/A
Net Income
$712.18K
+2.6%
EBITDA
$712.18K
-1978388.9%
Quarterly Fundamentals
Net Cash
$2.91M
-54.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$44.18K
N/A
Short Term Debt
$27.45K
N/A
Return on Assets
-1.09%
N/A
Return on Invested Capital
-1.18%
N/A
Free Cash Flow
$761.25K
-5.7%
Operating Cash Flow
$761.25K
-5.7%